These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 9247978

  • 1. Effect of neuroleptic treatment on depressive symptoms in acute schizophrenic episodes.
    Krakowski M, Czobor P, Volavka J.
    Psychiatry Res; 1997 Jun 16; 71(1):19-26. PubMed ID: 9247978
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reduced haloperidol does not interfere with the antipsychotic activity of haloperidol in the treatment of acute schizophrenia.
    Ulrich S, Neuhof S, Braun V, Meyer FP.
    Int Clin Psychopharmacol; 1999 Jul 16; 14(4):219-28. PubMed ID: 10468314
    [Abstract] [Full Text] [Related]

  • 7. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
    Zimbroff DL, Kane JM, Tamminga CA, Daniel DG, Mack RJ, Wozniak PJ, Sebree TB, Wallin BA, Kashkin KB.
    Am J Psychiatry; 1997 Jun 16; 154(6):782-91. PubMed ID: 9167505
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
    Tollefson GD, Beasley CM, Tran PV, Street JS, Krueger JA, Tamura RN, Graffeo KA, Thieme ME.
    Am J Psychiatry; 1997 Apr 16; 154(4):457-65. PubMed ID: 9090331
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.
    Riedel M, Mayr A, Seemüller F, Maier W, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Sauer H, Schneider F, Gaebel W, Jäger M, Möller HJ, Schennach-Wolff R.
    World J Biol Psychiatry; 2012 Jan 16; 13(1):30-8. PubMed ID: 21568628
    [Abstract] [Full Text] [Related]

  • 16. Risperidone in treatment-refractory schizophrenia.
    Wirshing DA, Marshall BD, Green MF, Mintz J, Marder SR, Wirshing WC.
    Am J Psychiatry; 1999 Sep 16; 156(9):1374-9. PubMed ID: 10484947
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia.
    Tollefson GD, Sanger TM, Beasley CM, Tran PV.
    Biol Psychiatry; 1998 Jun 01; 43(11):803-10. PubMed ID: 9611669
    [Abstract] [Full Text] [Related]

  • 19. Depressive symptoms and schizophrenic relapses: the effect of four neuroleptic drugs.
    Mauri MC, Bitetto A, Fabiano L, Laini V, Steinhilber C, Fornier M, Rafique F.
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Jan 01; 23(1):43-54. PubMed ID: 10368855
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.